Kuti Modupe A, Bamidele Olabisi T, Udeh Chioma T, Eseile Bola J, Ogundeji Olajumoke A
Department of Chemical Pathology, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Department of Chemical Pathology, University College Hospital, Ibadan, Nigeria.
Afr J Lab Med. 2022 Apr 29;11(1):1433. doi: 10.4102/ajlm.v11i1.1433. eCollection 2022.
Diabetes mellitus is a growing epidemic in Africa. Its diagnosis relies exclusively on laboratory evidence, which differs based on clinical circumstances.
The study described the appropriateness of plasma glucose test requests per the American Diabetes Association criteria.
We reviewed the plasma glucose test requests received by the chemical pathology laboratory of the University College Hospital, Ibadan, Nigeria between June 2018 and November 2018. The American Diabetes Association diabetes diagnostic criteria were used to define the appropriateness of test requests and determine the potential for ill-informed clinical decisions.
Four hundred and twenty-three requisition forms were included, with the majority from the medical wards/clinics (72.3%); the most frequent reason for a plasma glucose test was systemic hypertension (28.6%). Fasting plasma glucose was most requested (254; 60.0%). One hundred and sixteen (27.4%) requests were potentially inappropriate, with the 2-h postprandial plasma glucose (2hPPG) test requests (83; 71.6%) being the most inappropriate. The difference in the proportion of inappropriate requests was not statistically significantly between medical or surgical wards/clinics (Odds ratio 1.131, 95% confidence interval 0.709-1.803, = 0.605). Inappropriate requests in six cases may have triggered inappropriate action.
A third of the glucose tests requested for querying diabetes mellitus may have been inappropriate. Results of such testing may trigger inappropriate clinical action. To improve the quality of care and for economic reasons, laboratories should have programmes to improve the appropriate use of their services.
糖尿病在非洲正呈流行趋势。其诊断完全依赖实验室证据,而实验室证据会因临床情况而异。
本研究描述了根据美国糖尿病协会标准进行血浆葡萄糖检测申请的适宜性。
我们回顾了2018年6月至2018年11月期间尼日利亚伊巴丹大学学院医院化学病理实验室收到的血浆葡萄糖检测申请。采用美国糖尿病协会糖尿病诊断标准来界定检测申请的适宜性,并确定可能存在的临床决策依据不足的情况。
共纳入423份申请表,其中大多数来自内科病房/诊所(72.3%);进行血浆葡萄糖检测最常见的原因是系统性高血压(28.6%)。空腹血浆葡萄糖检测申请最多(254份;60.0%)。116份(27.4%)申请可能不合适,其中餐后2小时血浆葡萄糖(2hPPG)检测申请(83份;71.6%)最不合适。内科或外科病房/诊所之间不合适申请比例的差异无统计学意义(优势比1.131,95%置信区间0.709 - 1.803,P = 0.605)。6例不合适的申请可能已引发了不恰当的行为。
为排查糖尿病而申请的葡萄糖检测中,三分之一可能是不合适的。此类检测结果可能会引发不恰当的临床行为。为提高医疗质量并出于经济原因,实验室应制定相关计划以促进其服务的合理使用。